Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.
Vaxdyn has raised $12.8M in total funding. The most recent round was Series A. The last funding was announced in September 2026.
Vaxdyn's investors include European Innovation Council Fund, CARB-X, Reig Jofre, Biovance Capital, Arquimea Ingeniera.
Vaxdyn is headquartered in Sevilla, Spain.
Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.
Vaxdyn is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vaxdyn — Funding & Investors." VCBacked, September 7, 2026, https://www.vcbacked.co/company/vaxdyn. Accessed November 13, 2026.
VCBacked. (2026). Vaxdyn — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/vaxdyn
{{cite web |title=Vaxdyn — Funding & Investors |url=https://www.vcbacked.co/company/vaxdyn |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Vaxdyn? Request a listing update